Akoh J A
Plymouth Hospitals NHS Trust, Derriford Hospital, Plymouth PL6 8DH, United Kingdom.
Niger Postgrad Med J. 2001 Jun;8(2):99-103.
Indications for using central venous catheters (CVC) for haemodialysis include patients with: exhausted vascular access sites, no suitable vessels, failed peritoneal dialysis or short life expectancy. Catheter design and technology have changed in recent years to address the perennial problems of poor flow and infection. Permanent CVC offer a real alternative to arteriovenous access as 11-22% of long-term haemodialysis patients use CVC as their permanent vascular access. Recent advances in catheter use including measures to avoid insertion complications are highlighted. CVC provide mean flow rates of 274-525 ml/min with a one year cumulative catheter survival of 47-93%. Tunnelled CVC provide a safe and effective long-term access for haemodialysis and are particularly suitable for use in developing countries. They are cheaper to maintain and remove the temptation to re-use disposable dialysis needles.
使用中心静脉导管(CVC)进行血液透析的适应症包括:血管通路部位衰竭、没有合适血管、腹膜透析失败或预期寿命短的患者。近年来,导管设计和技术已经发生了变化,以解决长期存在的血流量不佳和感染问题。永久性CVC为动静脉通路提供了一种切实可行的替代方案,因为11%-22%的长期血液透析患者使用CVC作为其永久性血管通路。文中强调了导管使用方面的最新进展,包括避免插入并发症的措施。CVC的平均血流量为274-525毫升/分钟,导管一年累积生存率为47%-93%。带隧道的CVC为血液透析提供了一种安全有效的长期通路,特别适合在发展中国家使用。它们维护成本更低,且消除了重复使用一次性透析针的诱因。